- Title: Subtitle
- E2112: Randomized Phase 3 Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer: A Trial of the ECOG-ACRIN Cancer Research Group
- Creators
- Roisin M. Connolly - Univ Coll Cork, Cork, IrelandFengmin Zhao - DanaKathy D. Miller - Indiana UniversityMin-Jung Lee - NCI, Trepel Lab, Bethesda, MD 20892 USARichard L. Piekarz - NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USAKaren L. Smith - Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USAUrsa Brown-Glaberman - University of New MexicoJennifer S. Winn - Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USABryan A. Faller - New England Baptist HospitalAdedayo A. Onitilo - Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USAMark E. Burkard - Univ Wisconsin, Carbone Canc Ctr, Madison, WI USAGeorge T. Budd - Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USAEllis G. Levine - Roswell Pk Canc Inst, Buffalo, NY USAMelanie E. Royce - New Mexico MU NCORP, Albuquerque, NM USAPeter A. Kaufman - University of VermontAlexandra Thomas - Wake Forest UniversityJane B. Trepel - NCI, Trepel Lab, Bethesda, MD 20892 USAAntonio C. Wolff - Johns Hopkins UniversityJoseph A. Sparano - Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
- Resource Type
- Abstract
- Publication Details
- Clinical advances in hematology & oncology, Vol.19(2), pp.17-18
- Publisher
- Millennium Medical Publishing, Inc
- ISSN
- 1543-0790
- Number of pages
- 2
- Language
- English
- Date published
- 02/01/2021
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984700645802771
Abstract
E2112: Randomized Phase 3 Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer: A Trial of the ECOG-ACRIN Cancer Research Group
Clinical advances in hematology & oncology, Vol.19(2), pp.17-18
02/01/2021
Abstract
Details
Metrics
1 Record Views